PMID- 23583514 OWN - NLM STAT- MEDLINE DCOM- 20131126 LR - 20220408 IS - 1464-3405 (Electronic) IS - 0960-894X (Linking) VI - 23 IP - 10 DP - 2013 May 15 TI - Flaxseed (Linum usitatissimum L.) extract as well as (+)-secoisolariciresinol diglucoside and its mammalian derivatives are potent inhibitors of alpha-amylase activity. PG - 3007-12 LID - S0960-894X(13)00345-4 [pii] LID - 10.1016/j.bmcl.2013.03.029 [doi] AB - Type 2 diabetes mellitus (T2DM) is one of the common global diseases. Flaxseed is by far the richest source of the dietary lignans (i.e., secoisolariciresinol diglucoside) which have been shown to delay the development of T2DM in animal models. Herein, we propose the first evidences for a mechanism of action involving the inhibition of the pancreatic alpha-amylase (EC 3.2.1.1) by flaxseed-derived lignans that could therefore constitute a promising nutraceutical for the prevention and the treatment of T2DM. CI - Copyright (c) 2013 Elsevier Ltd. All rights reserved. FAU - Hano, Christophe AU - Hano C AD - Laboratoire de Biologie des Ligneux et des Grandes Cultures UPRES EA 1207, Equipe Lignanes des Linacees, Antenne Scientifique Universitaire de Chartres, 21 rue de Loigny la Bataille, F28000 Chartres, France. christophe.hano@univ-orleans.fr FAU - Renouard, Sullivan AU - Renouard S FAU - Molinie, Roland AU - Molinie R FAU - Corbin, Cyrielle AU - Corbin C FAU - Barakzoy, Esmatullah AU - Barakzoy E FAU - Doussot, Joel AU - Doussot J FAU - Lamblin, Frederic AU - Lamblin F FAU - Laine, Eric AU - Laine E LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130316 PL - England TA - Bioorg Med Chem Lett JT - Bioorganic & medicinal chemistry letters JID - 9107377 RN - 0 (Butylene Glycols) RN - 0 (Enzyme Inhibitors) RN - 0 (Glucosides) RN - 0 (Glycoside Hydrolase Inhibitors) RN - 0 (Lignans) RN - 0 (Plant Extracts) RN - EC 3.2.1.1 (Pancreatic alpha-Amylases) RN - EC 3.2.1.20 (alpha-Glucosidases) RN - M8QRJ7JEJH (secoisolariciresinol) SB - IM MH - Animals MH - Butylene Glycols/chemistry/isolation & purification/*pharmacology MH - Dose-Response Relationship, Drug MH - Enzyme Inhibitors/chemistry/isolation & purification/*pharmacology MH - Flax/*chemistry MH - Glucosides/chemistry/isolation & purification/*pharmacology MH - Glycoside Hydrolase Inhibitors MH - Intestines/enzymology MH - Lignans/chemistry/isolation & purification/*pharmacology MH - Molecular Structure MH - Pancreatic alpha-Amylases/*antagonists & inhibitors/metabolism MH - Plant Extracts/*chemistry MH - Rats MH - Structure-Activity Relationship MH - Swine MH - alpha-Glucosidases/metabolism EDAT- 2013/04/16 06:00 MHDA- 2013/12/16 06:00 CRDT- 2013/04/16 06:00 PHST- 2012/12/26 00:00 [received] PHST- 2013/03/05 00:00 [revised] PHST- 2013/03/07 00:00 [accepted] PHST- 2013/04/16 06:00 [entrez] PHST- 2013/04/16 06:00 [pubmed] PHST- 2013/12/16 06:00 [medline] AID - S0960-894X(13)00345-4 [pii] AID - 10.1016/j.bmcl.2013.03.029 [doi] PST - ppublish SO - Bioorg Med Chem Lett. 2013 May 15;23(10):3007-12. doi: 10.1016/j.bmcl.2013.03.029. Epub 2013 Mar 16.